{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:17:51Z","timestamp":1792603071343,"version":"4.5.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Left ventricular assist devices (LVADs) may reverse elevated pulmonary vascular resistance (PVR) which is associated with worse prognosis in heart failure (HF) patients. We aim to describe the temporal changes in hemodynamic parameters before and after LVAD implantation among patients with or without elevated PVR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HF patients who received continuous-flow LVAD (HeartMate 2&amp;amp;3) at a tertiary medical center and underwent right heart catheterization with PVR reversibility study before and after LVAD surgery. Patients were divided into 3 groups: normal PVR (&amp;lt;4WU); reversible PVR (initial PVR \u22654WU with positive reversibility); and non-reversible (persistent PVR \u22654WU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 85 LVAD patients with a mean age of 58 years (IQR 49\u201364), 65 patients (76%) were male; 60 patients had normal PVR, 20 patients with reversible and 5 patients with non-reversible PVR pre-LVAD. All patients with elevated PVR (\u22654WU) had higher pulmonary pressures (PP) and increased trans-pulmonary gradient (TPG) compared to patients with normal PVR (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). Patients with non-reversible PVR were more likely to have a significantly lower baseline cardiac output (CO) compared to all other groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2264 0.02). Hemodynamic parameters and PVR post LVAD were similar in all study groups. Patients with baseline elevated PVR (reversible and non-reversible) demonstrated a significant improvement in PP and TPG compared to patients with normal baseline PVR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2264 0.05). The improvement in CO and PVR post-LVAD in the non-reversible PVR group was significantly greater compared to all other groups (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.01). There were no significant differences between study groups in post LVAD and post heart transplantation course.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hemodynamic parameters improved after LVAD implantation, regardless of baseline PVR and reversibility, and enabled heart transplantation in patients who were ineligible due to non-reversible elevated PVR. Our findings suggest that mitigation of elevated non-reversible PVR is related to reduction in PP and increase in CO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2022.875204","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T02:26:03Z","timestamp":1650939963000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular Resistance"],"prefix":"10.3389","volume":"9","author":[{"given":"Avishay","family":"Grupper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Mazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobi","family":"Faierstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kurnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Maor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Elian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel M.","family":"Barbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Guetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lavee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension.","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases.","volume":"62","author":"Vachi\u00e9ry","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s1053-2498(99)00015-7","article-title":"Pulmonary hypertension: pathophysiology as a basis for clinical decision making.","volume":"18","author":"Rabinovitch","year":"1999","journal-title":"J Heart Lung Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/s1388-9842(03)00059-x","article-title":"Reversible pulmonary hypertension in heart transplant candidates\u2014pretransplant evaluation and outcome after orthotopic heart transplantation.","volume":"5","author":"Klotz","year":"2003","journal-title":"Eur J Heart Fail."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5492","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management.","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ."},{"key":"B6","first-page":"331","article-title":"Pulmonary vascular resistance and the risk of heart transplantation.","volume":"7","author":"Kirklin","year":"1988","journal-title":"J Heart Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/0002-8703(93)90704-d","article-title":"Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience.","volume":"126","author":"Murali","year":"1993","journal-title":"Am Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","article-title":"Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on peri-operative mortality.","volume":"114","author":"Chen","year":"1997","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.healun.2003.08.001","article-title":"Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics.","volume":"23","author":"Huang","year":"2004","journal-title":"J Heart Lung Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update.","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.24953\/turkjped.2020.03.013","article-title":"Management of pediatric cardiac transplantation candidates with pulmonary hypertension and high pulmonary vascular resistance.","volume":"62","author":"Yakut","year":"2020","journal-title":"Turk J Pediatr."},{"key":"B12","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jtcvs.2010.05.042","article-title":"Regression of \u201cfixed\u201d pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices.","volume":"140","author":"Beyersdorf","year":"2010","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jtcvs.2006.08.104","article-title":"Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.","volume":"133","author":"Zimpfer","year":"2007","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.ejcts.2008.12.024","article-title":"Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?","volume":"35","author":"Liden","year":"2009","journal-title":"Eur J Cardiothorac Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ejcts.2011.01.019","article-title":"Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.","volume":"40","author":"Mikus","year":"2011","journal-title":"Eur J Cardiothorac Surg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/ejcts\/ezs678","article-title":"Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.","volume":"43","author":"Kutty","year":"2013","journal-title":"Eur J Cardiothorac Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ehf2.13168","article-title":"Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates.","volume":"8","author":"Tavares-Silva","year":"2021","journal-title":"ESC Heart Fail."},{"key":"B19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cardfail.2021.01.004","article-title":"Understanding longitudinal changes in pulmonary vascular resistance after left ventricular assist device implantation.","volume":"27","author":"Gulati","year":"2021","journal-title":"J Card Fail."},{"key":"B20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.chest.2019.07.028","article-title":"Impact of the new pulmonary hypertension definition on heart transplant outcomes: expanding the hemodynamic risk profile.","volume":"157","author":"Crawford","year":"2020","journal-title":"Chest."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.875204\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T02:26:08Z","timestamp":1650939968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.875204\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":20,"alternative-id":["10.3389\/fcvm.2022.875204"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.875204","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"article-number":"875204"}}